Brainlab and Precision NeuroMed announce strategic partnership

This collaboration aims to standardize and scale the delivery of targeted therapies directly into brain tissue, helping overcome the limitations of the blood-brain barrier. By combining Brainlab expertise in medical imaging digitalization, surgical workflow integration, and precision planning with PNM’s proprietary molecular flow simulation software, the companies intend to create a cloud-based CED Treatment Planning System (CED TPS). The platform will use advanced imaging, simulation modeling, and AI-driven optimization to personalize drug distribution for each patient, improving precision, reproducibility, and clinical consistency.

Rainer Birkenbach, CEO of Brainlab SE, commented, “Together we’re working to provide clinicians with planning tools that aim to improve planning confidence and precision in treating some of the most complex neurological diseases.”

Dr. Sandeep Kunwar, CEO and Co-Founder of Precision NeuroMed, added, “Our goal is to establish a new standard for patient-specific, precise and reproducible treatment, beginning with glioblastoma and expanding to unlock disease-modifying therapies across some of the most serious neurological conditions.”

For more information, read the press release: https://precisionneuromed.com/brainlab-and-precision-neuromed-announce-partnership/